Evidence map›Paper›PMID 39057938›Full record

ReviewToxins2024

Residual Kidney Function in Hemodialysis: Its Importance and Contribution to Improved Patient Outcomes.

Yoshitsugu Obi, Jochen G Raimann, Kamyar Kalantar-Zadeh, Mariana Murea

Abstract readReview
In one paragraph

Review in Toxins, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Investigating circulating expression profile forFrontiers in molecular biosciences · 2025
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yoshitsugu ObiDivision of Nephrology, Department of Medicine, The University of Mississippi Medical Center, Jackson, MS 39216, USA.ORCID 0000-0001-7032-4383
Jochen G RaimannRenal Research Institute, New York, NY 10065, USA.ORCID 0000-0002-8954-2783
Kamyar Kalantar-ZadehTibor Rubin Veterans Affairs Long Beach Healthcare System, Long Beach, CA 90822, USA.ORCID 0000-0002-8666-0725
Mariana MureaDepartment of Internal Medicine, Section on Nephrology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA.

Funding

Tracking and Evaluation CoreU54GM115428 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI MASON, SARAH · 2016 to 2025
$38.2M
A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS TrialR01AG071803 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ALLON, MICHAEL, MUREA, MARIANA · 2021 to 2025
$5.6M
NIA NIH HHS R01 AG071803NIGMS NIH HHS U54 GM115428
6 · The paper itself

Abstract

Individuals afflicted with advanced kidney dysfunction who require dialysis for medical management exhibit different degrees of native kidney function, called residual kidney function (RKF), ranging from nil to appreciable levels. The primary focus of this manuscript is to delve into the concept of RKF, a pivotal yet under-represented topic in nephrology. To begin, we unpack the definition and intrinsic nature of RKF. We then juxtapose the efficiency of RKF against that of hemodialysis in preserving homeostatic equilibrium and facilitating physiological functions. Given the complex interplay of RKF and overall patient health, we shed light on the extent of its influence on patient outcomes, particularly in those living with advanced kidney dysfunction and on dialysis. This manuscript subsequently presents methodologies and measures to assess RKF, concluding with the potential benefits of targeted interventions aimed at preserving RKF.

Indexed as

KidneyRenal DialysisHumansTreatment Outcomeincremental hemodialysisrandomized controlled trialresidual kidney function

Identifiers

PMID39057938
PMCPMC11281084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.